Michael Loughnan

Thalidomide is an inhibitor of angiogenesis.

Robert J. D’Amato, Michael Loughnan, Evelyn Flynn et al. · Proceedings of the National Academy of Sciences · 1994 · 2.5K citations · Full text

Angiogenesis, Developmental Biology, Ophthalmology +13

Late Recurrences and the Necessity for Long-term Follow-up in Corneal and Conjunctival Intraepithelial Neoplasia

Geoffrey Tabin, Samantha Levin, Grant R. Snibson et al. · Ophthalmology · 1997 · 244 citations

Ocular Disease, Ophthalmology, Conjunctival Intraepithelial Neoplasia +7

Management of alkali burns

Stephen Brodovsky, Catherine A. McCarty, Grant R. Snibson et al. · Ophthalmology · 2000 · 186 citations

Fire Safety, Burn Management, Alkali Burns +4

Interleukins 4 and 5 control expression of IL-2 receptor on murine B cells through independent induction of its two chains

Michael Loughnan, G. J. V. Nossal · Nature · 1989 · 83 citations

Inflammation, Cytokine, Murine B Cells +12

T-cell-replacing factor (interleukin 5) induces expression of interleukin 2 receptors on murine splenic B cells.

Michael Loughnan, Kiyoshi Takatsu, Nobuyuki Harada et al. · Proceedings of the National Academy of Sciences · 1987 · 73 citations · Full text

Adaptive Immune System, Immunology, Immune Regulation +21